Zeitlicher Verlauf der Lebensqualit?t nach Prostatakarzinom

详细信息    查看全文

• 作者：M. Perl (1)
  A. Waldmann (2) Annika.Waldmann@uksh.de
  R. Pritzkuleit (1)
  A. Katalinic (12)
• 关键词：OVIS study – Quality of life – Predictors – Prostate cancer – Decision ; making in therapy
• 刊名：Der Urologe A
• 出版年：2012
• 出版时间：May 2012
• 年：2012
• 卷：51
• 期：5
• 页码：706-712
• 全文大小：540.0 KB
• 参考文献：1. Bestmann B, Loetters C, Diemer T et al (2007) Prostate-specific symptoms of prostate cancer in a German general population. Prostate Cancer Prostatic Dis 10:52–59
  2. Deck R (2008) Soziale Ungleichheit in der medizinischen Rehabilitation. Gesundheitswesen 70:582–589
  3. Deck R, R?ckelein E (1999) Zur Erhebung soziodemographischer und sozialmedizinscher Indikatoren in den rehabilitationswissenschaftlichen Forschungsverbünden. DRV-Schriften, Bd. 16 F?rderschwerpunkt ?Rehabilitationswissenschaften“; Empfehlungen der Arbeitsgruppen ?generische Methoden“, ?Routinedaten“, und ?Reha-?konomie“ Verband Deutsche Rentenversicherungstr?ger (Hrsg), Frankfurt am Main
  4. Fayers P, Aaronson N, Bjordal K et al (2001) The EORTC QLQ-C30 scoring manual. European Organization for Research and Treatment of Cancer, Brussels
  5. Hakamies-Blomquist L, Louma ML, Sjoestroem J et al (2001) Timing of quality of life (QoL) assessments as a source of error in oncological trails. J Adv Nurs 35:709–716
  6. Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80
  7. J?nler M, Nielsen OS, Groenvold M et al (2005) Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group study 5. Scandinavian J Urol Nephrol 39:42–48
  8. Korfage IJ, de Koning HJ, Habbema JD et al (2007) Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls? BJU Int 99:801–806
  9. Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139–144
  10. Rees J, Clarke MG, Waldron D et al (2005) The measurement of response shift in patients with advanced prostate cancer and their partners. Health Qual Life Outcomes 3:21
  11. Repetto L, Ausili-Cefaro G, Rossi A, Manzione L (2001) Quality of life in elderly cancer patients. Ann Oncol 12:49–52
  12. Robert Koch-Institut, Gesellschaft epidemiologischer Krebsregister in Deutschland (2010) Krebs in Deutschland 2005/2006. H?ufigkeiten und Trends. Westkreuz-Druckerei, Berlin
  13. Rohde V, Wasem J, Katalinic A (2007) Gesundheitsberichterstattung des Bundes, Heft 36: Prostataerkrankungen. RKI, Berlin
  14. Sanda MG, Dunn RL, Michalski J et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358:1250–1261
  15. Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37:1345–1351
  16. Sprangers MA, Schwartz CE (1999) Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48:1507–1515
  17. Sullivan PW, Mulani PM, Fishman M, Sleep D (2007) Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer. Qual Life Res 16:571–575
  18. Ubel PA, Loewenstein G, Jepson C (2003) Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res 12:599–607
  19. Waldmann A, Dreckschmidt J, Pritzkuleit R, Katalinic A (2010) Reliabilit?t des OVIS-Fragebogens – ein Instrument zur Evaluation der onkologischen Versorgung aus Patientensicht. Gesundheitswesen 72:707–713
  20. Waldmann A, Rohde V, Bremner K et al (2009) Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P). BMC Cancer 9:295
  21. Waldmann A, Rohde V, Kuechler T, Katalinic A (2009) German version of PORPUS-P: reference values, reliability, construct validity, discriminant and concurrent validity. In: Hoffmann E (Hrsg) Health related quality of life. Public Health in the 21st Century. Nova Biomedical Books, New York, pp 85–104
  22. Zhou ES, Penedo FJ, Bustillo NE et al (2010) Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer. J Support Oncol 8:196–201
  23. Zhou ES, Penedo FJ, Lewis JE et al (2007) Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer. J Psychosom Res 69:587–590
• 作者单位：1. Institut für Krebsepidemiologie e.V., Lübeck, Deutschland2. Institut für Klinische Epidemiologie, Ratzeburger Allee 160 (Haus 50), 23562 Lübeck, Deutschland
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Urology and Andrology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-0563

文摘

Hintergrund Für das lokal begrenzte Prostatakarzinom sind die operative und die Strahlentherapie mit ?hnlicher Prognose (5-Jahres-überlebenswahrscheinlichkeit: 83–94%), jedoch mit unterschiedlichen Nebenwirkungsprofilen verbunden. Bei derart guter Prognose kann die posttherapeutische gesundheitsbezogene Lebensqualit?t (LQ) wichtig für die Therapieentscheidungsfindung sein.